N

Nortem BioGroup
MLBIO

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€13.92M
EV
-
Shares Outstanding
2.58M
Beta
0.00
Industry
-

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2020E
-
P/Revenue 2020E
-

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2020E
-
Net Profit Margin 2020E
-
ROE 2020E
-
ROCE 2019
-

Dividends

DPS 2020E
-
Payout Ratio 2020E
-
Div. Yield 2020E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Nortem BioGroup

gainify

N

Nortem BioGroup

MLBIO

Nortem BioGroup manufactures and markets natural products based on organic and biodegradable substances in Italy. The company provides food grade citric acid and sodium bicarbonate; Epson and Himalayan salt; spices, such as organic turmeric, ginger, and black pepper p...

Sector

Industry

CEO

Data Unavailable

Employees

0

IPO Date

Headquarters

Calle Alexandro Humbold, No 12, El Puerto de Sta MarIa, Cádiz, Andalusia, 11500, Spain

📊 Stock Price & Performance

The last closing price of Nortem BioGroup (MLBIO) is €5.40, reflecting a +0.00% change from the prior session. Last updated: February 15, 2026 at 5:32 PM Eastern Time

Review of Recent MLBIO Stock Performance trends:Past 3 Months: The stock recorded a change of -5.20%. Last updated: February 15, 2026 at 5:32 PM Eastern Time

Nortem BioGroup (MLBIO) is considered a low volatility stock. It has a beta of 0.00, which means it typically moves 0.00 times as much as the broader market. Last updated: February 15, 2026 at 5:32 PM Eastern Time

💰 Financial Metrics & Reports

The current Nortem BioGroup (MLBIO) market capitalization is approximately €13.92M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Nortem BioGroup's market cap fluctuates with changes in its share price and share count. Last updated: February 15, 2026 at 5:32 PM Eastern Time

In the most recently reported fiscal year, Nortem BioGroup (MLBIO) generated net income of €137.98K. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions.

📅 Earnings & Dividends

Nortem BioGroup (MLBIO) does not currently pay a dividend. Over the last twelve months (LTM), the company paid €0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.

📈 Analyst Information

Based on the latest available analyst coverage, Nortem BioGroup (MLBIO) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: February 15, 2026 at 5:32 PM Eastern Time

Like other publicly traded stocks, Nortem BioGroup (MLBIO) shares are bought and sold on stock exchanges such as ENXTPA and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Nortem BioGroup (MLBIO) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add MLBIO to your watchlist.

Nortem BioGroup trades under the ticker symbol MLBIO on the ENXTPA stock exchange. The ticker MLBIO is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

Nortem BioGroup (MLBIO) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Nortem BioGroup (MLBIO) stock peers based on overlapping products, services, and competitive dynamics:Applied Nutrition (APN) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Nortem BioGroup.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.